Research.Patient.info
Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double‑blind, Placebo‑controlled, Dose‑finding Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants with Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
This study is testing a new medicine, ALXN2050, for adults with kidney diseases called lupus nephritis or IgA nephropathy. Researchers want to see if the medicine can reduce protein in the urine and if it's safe.
Germany · Spain · Italy - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
This study is testing a new medicine, Ultomiris, for adults with kidney diseases called Lupus Nephritis or IgA Nephropathy. Doctors want to see if it reduces protein in their urine and helps their kidneys work better, compared to a dummy medicine.
Italy · Poland · Spain